RxDoctor Payments Data

Grace Reid, MD

Psychiatry · Redlands, CANPI 1881747889

Payments from drug & device makers

$1,984in general payments, 2019–2025

Across 146 payments — averaging $13.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$298
  • Otsuka America Pharmaceutical, Inc.$244
  • Takeda Pharmaceuticals U.S.A., Inc.$205
  • Alkermes, Inc.$193
  • Neurocrine Biosciences, Inc.$175
  • Teva Pharmaceuticals USA, Inc.$165
  • plus $705 from 13 others

What the payments were for

  • Food & beverage$1,984100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,984 in reported general payments places this provider in the 80th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$24,422
Medicare patients
26
Services billed
206

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine17$96,730
Wellbutrin XlBupropion Hcl11$64,856
RexultiBrexpiprazole26$40,093
Lurasidone Hcl52$38,020
BelsomraSuvorexant15$6,677
CymbaltaDuloxetine Hcl13$6,073
Quetiapine Fumarate161$1,684
Vilazodone Hcl11$1,682
Perphenazine16$1,261
Gabapentin70$1,231
Duloxetine Hcl83$1,181
Divalproex Sodium ErDivalproex Sodium32$1,135
Hydroxyzine Hcl28$981
Buspirone Hcl55$808
Bupropion XlBupropion Hcl28$751

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$165$96,73017 claims
Otsuka America Pharmaceutical, Inc.Rexulti$244$40,09326 claims
MerckBelsomra$14$6,67715 claims
Almatica Pharma LLCSertraline Hcl$19$1717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Redlands

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →